Grufity logo
Grufity logo

Latest Vestal Point Capital, LP Stock Portfolio

$3.58Billion | No. of Holdings #90

Vestal Point Capital, LP Performance

2026 Q1+0.96%
YTD+0.96%
2025+15.37%

About Vestal Point Capital, LP and 13F Hedge Fund Stock Holdings

Vestal Point Capital, LP is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vestal Point Capital, LP reported an equity portfolio of $3.6 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Vestal Point Capital, LP are RVMD, BMRN, . The fund has invested 6.5% of it's portfolio in REVOLUTION MEDICINES INC and 5.7% of portfolio in BIOMARIN PHARMACEUTICAL INC. <br><br> The fund managers got completely rid off ARCELLX INC (ACLX), DEXCOM INC (DXCM) and MERCK & CO INC (MRK) stocks. They significantly reduced their stock positions in TYRA BIOSCIENCES INC (TYRA), TERNS PHARMACEUTICALS INC (TERN) and GERON CORP (GERN). Vestal Point Capital, LP opened new stock positions in NEUROCRINE BIOSCIENCES INC (NBIX), SANOFI SA (SNY) and BOSTON SCIENTIFIC CORP (BSX). The fund showed a lot of confidence in some stocks as they added substantially to DYNE THERAPEUTICS INC (DYN), REPLIGEN CORP (RGEN) and NUVALENT INC (NUVL).
Vestal Point Capital, LP Equity Portfolio Value
Last Reported on: 15 May, 2026
$3.58Billion
  as of May 15, 2026

Vestal Point Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Vestal Point Capital, LP made a return of 0.96% in the last quarter. In trailing 12 months, it's portfolio return was 35.73%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
neurocrine biosciences inc164,675,000
sanofi sa67,452,000
boston scientific corp50,200,000
cogent biosciences inc47,376,900
united therapeutics corp44,473,500
bright minds biosciences inc35,924,500
protagonist therapeutics inc34,377,200
regeneron pharmaceuticals inc30,905,600
New stocks bought by Vestal Point Capital, LP

Additions

Ticker% Inc.
dyne therapeutics inc3,233
repligen corp1,014
nuvalent inc947
revolution medicines inc705
immunocore holdings plc372
monte rosa therapeutics inc364
bristol-myers squibb co300
denali therapeutics inc281
Additions to existing portfolio by Vestal Point Capital, LP

Reductions

Ticker% Reduced
tyra biosciences inc-97.77
terns pharmaceuticals inc-77.78
geron corp-77.56
olema pharmaceuticals inc-74.03
novocure ltd-52.38
globus medical inc-52.12
alcon ag-27.6
nyxoah sa-21.53
Vestal Point Capital, LP reduced stake in above stock

Sold off

Ticker$ Sold
day one biopharmaceuticals inc-48,464,000
arcellx inc-190,710,000
fate therapeutics inc-1,694,980
rezolute inc-3,978,960
dexcom inc-84,621,800
black diamond therapeutics inc-2,114,100
zymeworks inc-22,775,400
merck & co inc-81,576,500
Vestal Point Capital, LP got rid off the above stocks

Sector Distribution

Vestal Point Capital, LP has about 65.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare65.7
Others33.9

Market Cap. Distribution

Vestal Point Capital, LP has about 26% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • LARGE-CAP
  • MID-CAP
  • SMALL-CAP
Category%
UNALLOCATED33.9
LARGE-CAP26
MID-CAP22.6
SMALL-CAP16.3

Stocks belong to which Index?

About 41.7% of the stocks held by Vestal Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others58.3
RUSSELL 200035.6
S&P 5006.1
Top 5 Winners (%)%
enliven therapeutics inc
142.8 %
MGNX
macrogenics inc
79.5 %
crescent biopharma inc
54.9 %
tectonic therapeutic inc
48.2 %
TENX
tenax therapeutics inc
31.2 %
Top 5 Winners ($)$
enliven therapeutics inc
84.3 M
TERN
terns pharmaceuticals inc
33.9 M
RVMD
revolution medicines inc
23.5 M
TYRA
tyra biosciences inc
14.9 M
bicara therapeutics inc
13.8 M
Top 5 Losers (%)%
beta bionics inc
-56.5 %
lexeo therapeutics inc
-42.2 %
PASG
passage bio inc
-33.5 %
nyxoah sa
-32.6 %
RGNX
regenxbio inc
-32.0 %
Top 5 Losers ($)$
abivax sa
-40.0 M
beta bionics inc
-28.7 M
RGEN
repligen corp
-23.2 M
NRIX
nurix therapeutics inc
-19.4 M
lexeo therapeutics inc
-18.8 M

Vestal Point Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vestal Point Capital, LP

Vestal Point Capital, LP has 90 stocks in it's portfolio. About 40.4% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Vestal Point Capital, LP last quarter.

$3.58BTotal Value
112Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Vestal Point Capital, LP, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ALC
Alcon Ag

Alcon Ag

ALC
Vestal Point Capital, LP's holding in Alcon Ag over time
1.69%800,000
$60.28M
1.69%
decreased 27.6 percentreduced
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Vestal Point Capital, LP's holding in Ascendis Pharma A/S over time
2.4%375,000
$85.77M
2.4%
increased 114.29 percentadded